GGrantIndex
← Leaderboards

Xiaoxin Chen

Rutgers The St Univ Of Nj New Brunswick

$13,268,459
Attributed
$16,310,637
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,310,637 · 14

By mechanism

U54$8,565,514 · 8
R01$6,614,858 · 3
R21$1,130,265 · 3

Top collaborators

Others in their field

Top investigators on “In Vivo

Research focus

In VivoGenesFutureMolecularMalignant NeoplasmsGeneticTissuesIn VitroResponseEsophagusPhenotypeTranscription FactorApplications GrantsGenetic TranscriptionEpithelial CellsAnimal ModelSignal TransductionPathway InteractionsCellsCancer TypeAnticancer ResearchGrantHistopathologyMediating

Grant awards (56)

Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$618,054
R01 · FY2025 · CA · contact PI
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology$579,108
R01 · FY2025 · AA · contact PI
Triacetin Treatment for Propionic Acidemia by Rebalancing the Acetyl-CoA/Propionyl-CoA Metabolism$246,148
R21 · FY2025 · TR
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$606,975
R01 · FY2024 · CA · contact PI
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology$589,786
R01 · FY2024 · AA · contact PI
Triacetin Treatment for Propionic Acidemia by Rebalancing the Acetyl-CoA/Propionyl-CoA Metabolism$184,617
R21 · FY2024 · TR
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$154,586
R01 · FY2024 · CA · contact PI
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology$616,892
R01 · FY2023 · AA · contact PI
NRF2-ACSS2 Axis in Alcohol-induced Metabolic Reprogramming and Esophageal Pathology$573,301
R01 · FY2022 · AA · contact PI
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$397,420
R01 · FY2022 · CA · contact PI
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$169,196
R01 · FY2022 · CA · contact PI
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$83,443
R01 · FY2022 · CA · contact PI
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$81,195
R01 · FY2022 · CA · contact PI
Research Infrastructure Core (RIC)$750,523
U54 · FY2021 · MD · contact PI
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$609,361
R01 · FY2021 · CA · contact PI
Research Infrastructure Core (RIC)$877,538
U54 · FY2020 · MD · contact PI
Mechanisms and Targeted Therapy of NRF2-high Esophageal Squamous Cell Carcinoma$574,275
R01 · FY2020 · CA · contact PI
NOTCH-PAX9 signaling in alcohol-induced esophageal injury$212,750
R21 · FY2020 · AA · contact PI
Histopathology Core-Shared Resources$68,748
U54 · FY2020 · CA · contact PI
Full Project 5: Mechanisms and Targeted Therapy of Nrf2high Esophageal Squamous Cell Carcinoma$68,746
U54 · FY2020 · CA · contact PI
Research Infrastructure Core (RIC)$929,855
U54 · FY2019 · MD · contact PI
Histopathology Core-Shared Resources$200,595
U54 · FY2019 · CA · contact PI
NOTCH-PAX9 signaling in alcohol-induced esophageal injury$175,750
R21 · FY2019 · AA · contact PI
Research Infrastructure Core (RIC)$986,693
U54 · FY2018 · MD · contact PI
Diagnostic and Molecular Histopathology Core$76,221
U54 · FY2018 · CA · contact PI
Research Infrastructure Core (RIC)$1,562,873
U54 · FY2017 · MD · contact PI
Pilot Project 2: Nrf2 Activation in Esophageal Squamous Cell Carcinogenesis In Vivo$94,385
U54 · FY2017 · CA · contact PI
Diagnostic and Molecular Histopathology Core$75,506
U54 · FY2017 · CA · contact PI
Pilot Project 2: Nrf2 Activation in Esophageal Squamous Cell Carcinogenesis In Vivo$107,999
U54 · FY2016 · CA · contact PI
Diagnostic and Molecular Histopathology Core$86,399
U54 · FY2016 · CA · contact PI
Pilot Project 2: Nrf2 Activation in Esophageal Squamous Cell Carcinogenesis In Vivo$108,000
U54 · FY2015 · CA · contact PI
Diagnostic and Molecular Histopathology Core$86,399
U54 · FY2015 · CA · contact PI
RC2 Oxidative Stress in Alcohol-associated Oral Carcinogenesis$161,190
U54 · FY2014 · AA · contact PI
Resource/Infrastructure Development Core$42,321
U54 · FY2014 · CA · contact PI
Oxidative Stress in Alcohol-associated Oral Carcinogenesis$35,155
U54 · FY2014 · AA · contact PI
RC2 Oxidative Stress in Alcohol-associated Oral Carcinogenesis$151,054
U54 · FY2013 · AA · contact PI
Resource/Infrastructure Development Core$102,669
U54 · FY2013 · CA · contact PI
Oxidative Stress in Alcohol-associated Oral Carcinogenesis$33,764
U54 · FY2013 · AA · contact PI
Racial Disparity in Barrett's Esophagus$426,046
U54 · FY2012 · CA · contact PI
RC2 Oxidative Stress in Alcohol-associated Oral Carcinogenesis$167,998
U54 · FY2012 · AA · contact PI
Resource/Infrastructure Development Core$48,887
U54 · FY2012 · CA · contact PI
Oxidative Stress in Alcohol-associated Oral Carcinogenesis$36,200
U54 · FY2012 · AA · contact PI
Racial Disparity in Barrett's Esophagus$416,257
U54 · FY2011 · CA · contact PI
RC2 Oxidative Stress in Alcohol-associated Oral Carcinogenesis$169,424
U54 · FY2011 · AA · contact PI
Resource/Infrastructure Development Core$44,148
U54 · FY2011 · CA · contact PI
Oxidative Stress in Alcohol-associated Oral Carcinogenesis$36,199
U54 · FY2011 · AA · contact PI
Racial Disparity in Barrett's Esophagus$358,116
U54 · FY2010 · CA · contact PI
RC2 Oxidative Stress in Alcohol-associated Oral Carcinogenesis$171,927
U54 · FY2010 · AA · contact PI
Resource/Infrastructure Development Core$47,114
U54 · FY2010 · CA · contact PI
Oxidative Stress in Alcohol-associated Oral Carcinogenesis$36,565
U54 · FY2010 · AA · contact PI
Chemoprevention of Tobacco-related Oral Carcinogenesis$244,328
R01 · FY2005 · CA
Chemoprevention of Tobacco-related Oral Carcinogenesis$85,610
R01 · FY2005 · CA
Chemoprevention of Tobacco-related Oral Carcinogenesis$320,328
R01 · FY2004 · CA
Chemoprevention of Tobacco-related Oral Carcinogenesis$311,000
R01 · FY2003 · CA
Animal Model of Barrett's Esophagus$155,500
R21 · FY2003 · DK
Animal Model of Barrett's Esophagus$155,500
R21 · FY2002 · DK